ATE463500T1 - Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung - Google Patents

Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung

Info

Publication number
ATE463500T1
ATE463500T1 AT01964579T AT01964579T ATE463500T1 AT E463500 T1 ATE463500 T1 AT E463500T1 AT 01964579 T AT01964579 T AT 01964579T AT 01964579 T AT01964579 T AT 01964579T AT E463500 T1 ATE463500 T1 AT E463500T1
Authority
AT
Austria
Prior art keywords
phosphonamide
ring
template
derived
production
Prior art date
Application number
AT01964579T
Other languages
English (en)
Inventor
Paul Hanson
Kevin Sprott
Matthew Mcreynolds
Original Assignee
Univ Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kansas filed Critical Univ Kansas
Application granted granted Critical
Publication of ATE463500T1 publication Critical patent/ATE463500T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2462Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of unsaturated acyclic amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/26Amides of acids of phosphorus containing P-halide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65848Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT01964579T 2000-08-15 2001-08-06 Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung ATE463500T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/639,051 US6420586B1 (en) 2000-08-15 2000-08-15 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
PCT/US2001/041606 WO2002014344A2 (en) 2000-08-15 2001-08-06 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same

Publications (1)

Publication Number Publication Date
ATE463500T1 true ATE463500T1 (de) 2010-04-15

Family

ID=24562532

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07008428T ATE503761T1 (de) 2000-08-15 2001-08-06 Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese
AT01964579T ATE463500T1 (de) 2000-08-15 2001-08-06 Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07008428T ATE503761T1 (de) 2000-08-15 2001-08-06 Von aminosäuren abgeleitete, zyklische phosphonamide und verfahren zu deren synthese

Country Status (9)

Country Link
US (1) US6420586B1 (de)
EP (2) EP1806351B1 (de)
JP (1) JP5249486B2 (de)
AT (2) ATE503761T1 (de)
AU (1) AU2001285418A1 (de)
CA (1) CA2419775C (de)
DE (2) DE60141757D1 (de)
DK (2) DK1311515T3 (de)
WO (1) WO2002014344A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006293A1 (en) * 2000-07-18 2002-01-24 Leo Pharma A/S Matrix metalloproteinase inhibitors
CA2470649A1 (en) * 2002-01-18 2003-07-24 Leo Pharma A/S Mmp inhibitors
MXPA04010527A (es) 2002-04-26 2004-12-13 Gilead Sciences Inc Acumulacion celular de analogos de fosfonato de los compuestos inhibidores de la proteasa del virus de inmunodeficiencia humana (vih).
US7429565B2 (en) 2003-04-25 2008-09-30 Gilead Sciences, Inc. Antiviral phosphonate analogs
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
WO2004096287A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
KR20060022647A (ko) 2003-04-25 2006-03-10 길리애드 사이언시즈, 인코포레이티드 키나아제 억제 포스포네이트 유사체
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
WO2004096285A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Anti-infective phosphonate conjugates
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
WO2005044308A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
US7427624B2 (en) 2003-10-24 2008-09-23 Gilead Sciences, Inc. Purine nucleoside phosphorylase inhibitory phosphonate compounds
EP1678322A2 (de) 2003-10-24 2006-07-12 Gilead Sciences, Inc. Verfahren und zusammensetzungen zur identifizierung therapeutischer verbindungen
NZ547907A (en) 2003-12-22 2010-07-30 Gilead Sciences Inc 4'-Substituted carbovir-and abacavir-derivatives as well as related compounds with HIV and HCV antiviral activity
ES2720618T3 (es) 2004-07-27 2019-07-23 Gilead Sciences Inc Análogos de fosfonato de compuestos de inhibidores de VIH
US8592336B2 (en) 2006-04-11 2013-11-26 Agency For Science, Technology And Research Catalysts for ring-closing metathesis
EP2010318B1 (de) * 2006-04-11 2014-04-02 Agency for Science, Technology and Research Katalysatoren für ringschlussmetathese
KR101642527B1 (ko) 2008-07-08 2016-07-25 길리애드 사이언시즈, 인코포레이티드 Hiv 억제제 화합물의 염
JP2013023454A (ja) * 2011-07-19 2013-02-04 Katayama Kagaku Kogyo Kk ハロゲン化有機リン化合物の製造方法
WO2019027920A1 (en) 2017-08-01 2019-02-07 Gilead Sciences, Inc. CRYSTALLINE FORMS OF ETHYL ((S) - (((((2R, 5R) -5- (6-AMINO-9H-PURIN-9-YL) -4-FLUORO-2,5-DIHYDROFURAN-2-YL) OXY ) METHYL) (PHENOXY) PHOSPHORYL) -L-ALANINATE (GS-9131) FOR THE TREATMENT OF VIRAL INFECTIONS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3329687A (en) 1964-01-16 1967-07-04 Sandoz Ag Thiadiazepinedioxides and their preparation
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
EP1251135A3 (de) 1992-04-03 2004-01-02 California Institute Of Technology Hochwirksame Ruthenium- und Osmium- Metall-Carbenkomplexe für die Olefinmetathesereaktionen, und deren Herstellung
US5312940A (en) 1992-04-03 1994-05-17 California Institute Of Technology Ruthenium and osmium metal carbene complexes for olefin metathesis polymerization
US5710298A (en) 1992-04-03 1998-01-20 California Institute Of Technology Method of preparing ruthenium and osmium carbene complexes
AU703962B2 (en) * 1993-02-26 1999-04-01 Du Pont Pharmaceuticals Company Substituted cyclic carbonyls and derivatives
US5543517A (en) * 1994-01-13 1996-08-06 The Dupont Merck Pharmaceutical Company Substituted bicyclic phosphoramides and derivatives thereof
US6083711A (en) 1996-05-15 2000-07-04 Smithkline Beecham Corporation Proteases compositions capable of binding to said site, and methods of use thereof
US5917071A (en) 1996-11-15 1999-06-29 California Institute Of Technology Synthesis of ruthenium or osmium metathesis catalysts
AU2074699A (en) 1998-01-26 1999-08-09 Yamanouchi Pharmaceutical Co., Ltd. Novel benzene-fused heterocyclic derivatives or salts thereof

Also Published As

Publication number Publication date
DE60144349D1 (de) 2011-05-12
CA2419775A1 (en) 2002-02-21
CA2419775C (en) 2014-12-02
WO2002014344A2 (en) 2002-02-21
EP1806351B1 (de) 2011-03-30
EP1806351A2 (de) 2007-07-11
EP1311515A2 (de) 2003-05-21
US6420586B1 (en) 2002-07-16
WO2002014344A3 (en) 2002-09-06
AU2001285418A1 (en) 2002-02-25
EP1806351A3 (de) 2007-09-26
DE60141757D1 (de) 2010-05-20
JP2004506646A (ja) 2004-03-04
DK1806351T3 (da) 2011-07-18
EP1311515A4 (de) 2003-12-03
ATE503761T1 (de) 2011-04-15
JP5249486B2 (ja) 2013-07-31
DK1311515T3 (da) 2010-07-19
EP1311515B1 (de) 2010-04-07

Similar Documents

Publication Publication Date Title
DE60141757D1 (de) Von aminosäuren abgeleitete zyklische phosphonamide und verfahren zu deren herstellung
DE69819699T2 (de) Verfahren zur Herstellung von multiaxialen Vliesstoffen
NO973335D0 (no) Fremgangsmåte for fremstilling av et flertall kjemiske stoffer i en tabelloppstilling
DE3583361D1 (de) Verfahren zur herstellung von thrombin-inhibitoren.
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
DE69809685D1 (de) Verfahren zur Herstellung von Olefinen durch direkte Umsetzung mehrerer Kohlenwasserstoffe
DE69812489D1 (de) Korrosionsbeständiges Bauteil, Waferträger und Verfahren zu deren Herstellung
ATE240938T1 (de) Verfahren zur herstellung von alkansulfonsäuren
MY136437A (en) Methods and apparatus for nucleic acid sequencing by signal stretching and data intergration
ATE191748T1 (de) Verfahren zum nachweis ähnlicher nukleinsäuren
DE69829722D1 (de) Verfahren zur Herstellung von Katalysatoren zur Verwendung in Umwandlungsreaktionen von organischen Verbindungen
DE69900462D1 (de) Konjugate von dns und pns und verfahren zu deren herstellung
DE3866564D1 (de) Verfahren zum herstellen von spritzgegossenen schiebern fuer reissverschluesse.
DE3683536D1 (de) Verfahren zur herstellung von organischen pigmenten.
DE69833200D1 (de) Verfahren für die produktion von l-glutaminsäure mittels fermentation
DE69910113D1 (de) Verfahren zur Herstellung von Stickstofftrifluorid durch Gas-Feststoffreaktion
ATE261981T1 (de) Verfahren zur herstellung von alkylphosphonsäuren
DK1105508T3 (da) Fremgangsmåde til oprensning af biomolekyle- eller proteinkomplekser
ATE234827T1 (de) Verfahren zur herstellung von 3-aryl- benzofuranonen
EP1336603A4 (de) Verfahren zur einführung von aminogruppen und verfahren zur synthese von aminosäuren
ATE159521T1 (de) Thioacylierungsmittel und zwischenprodukte, thiopeptide, und verfahren zu deren herstellung und anwendung
DE50004236D1 (de) Verfahren zur Herstellung von 1,1,4,4-Tetramethoxybuten-2
ATE271561T1 (de) Verfahren zur herstellung von einer amid verbindung
ATE231492T1 (de) Verfahren zur herstellung von pyrrolamiden
ATE235461T1 (de) Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties